4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-ol

Catalog No. :
ACEHDC578
CAS No. :
2248157-58-4
Molecular Formula :
C15H18BNO3
Molecular Weight :
271.13

IUPAC Name:4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-ol

4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$297.00Login to see priceInquiryInquiry
1g95%$742.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-ol
IUPAC Name4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-ol
MDL No.MFCD27936542
Molecular FormulaC15H18BNO3
Molecular Weight271.13
SMILESCC1(C)OB(OC1(C)C)C1=C2C=CC=CC2=C(O)N=C1
InChI KeyYDWXMSRZTFXPKE-UHFFFAOYSA-N
Synonym1(2H)-Isoquinolinone, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-ol
CAS No.2248157-58-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEHDC578 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACTCKH182 route compound structure diagram
    ACTCKH1823951-95-9 In Stock
  4. Then
  5. ACEHDC578 route product structure diagram
    ACEHDC5782248157-58-4
Inquiry

2. ACEHDC578 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACEICQ670 route compound structure diagram
    ACEICQ670927801-74-9 In Stock
  4. Then
  5. ACEHDC578 route product structure diagram
    ACEHDC5782248157-58-4
Inquiry

Comments (0)